Image Analysis | Tissuepathology.com

Indica Labs: Boston University Digital Pathology Core Case Study

Erica Goodpaster — Fri, 28 Aug 2026 11:50:13 +0000

From Indica Labs: No matter their organizational setting, digital pathology cores routinely provide researchers with access to advanced imaging and analysis capabilities and institutional expertise that expand the possibilities of scientific studies. The Boston University Digital Pathology Core supports researchers across BU’s Alzheimer’s Disease Research Center, Chronic Traumatic Encephalopathy Center, Boston Medical Center, and broader […]

The post Indica Labs: Boston University Digital Pathology Core Case Study first appeared on Tissuepathology.com.

Tempus Study Published in Nature Medicine Demonstrates Best-in-Class Performance of PRISM2 Across Diagnostic and Prognostic Applications

Erica Goodpaster — Thu, 27 Aug 2026 13:04:38 +0000

Tempus’ multimodal foundation model offers diagnostic-grade precision for cancer detection and unlocks broader applications predicting biomarker status and patient prognosis CHICAGO, August 4, 2026 — Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care, today announced study results demonstrating that PRISM2, a multimodal slide-level pathology […]

The post Tempus Study Published in Nature Medicine Demonstrates Best-in-Class Performance of PRISM2 Across Diagnostic and Prognostic Applications first appeared on Tissuepathology.com.

Ataraxis AI’s Laboratory Receives CAP Accreditation and California Clinical Laboratory License

Erica Goodpaster — Wed, 26 Aug 2026 12:15:44 +0000

NEW YORK–(BUSINESS WIRE)–Ataraxis AI, a frontier clinical artificial intelligence (AI) company developing AI-powered tools for oncology, today announced that its laboratory has received accreditation from the College of American Pathologists (CAP) and a clinical laboratory license from the State of California, expanding access to the Ataraxis Breast platform for clinicians and patients across the state. […]

The post Ataraxis AI’s Laboratory Receives CAP Accreditation and California Clinical Laboratory License first appeared on Tissuepathology.com.

Stratipath and Aiforia partner to expand access to AI-driven precision diagnostics in oncology

Erica Goodpaster — Tue, 25 Aug 2026 12:23:25 +0000

August 25, 2026 – Stratipath, a leader in AI-based precision diagnostics for breast cancer, and Aiforia, a pioneer in AI-driven diagnostics in pathology, today announced a strategic partnership. This collaboration aims to provide pathologists and oncologists with broader access to validated AI-powered diagnostic and prognostic tools and sets the stage for a long-term commercial relationship […]

The post Stratipath and Aiforia partner to expand access to AI-driven precision diagnostics in oncology first appeared on Tissuepathology.com.

Gestalt: Why Healthcare IT Staff Augmentation Is Replacing Traditional Hiring in 2026

Erica Goodpaster — Mon, 24 Aug 2026 12:37:51 +0000

From the Gestalt blog: Healthcare IT isn’t shrinking, it’s resetting. After the surge of pandemic-era hiring, many health systems are stepping back and asking a hard question: does more headcount actually make us more agile? In 2026, with tighter margins, AI initiatives accelerating, and cybersecurity demands rising, the answer often isn’t yes. Fixed labor costs can […]

The post Gestalt: Why Healthcare IT Staff Augmentation Is Replacing Traditional Hiring in 2026 first appeared on Tissuepathology.com.

Proscia: Getting to Know Kary Rogers: A Conversation with Proscia’s Head of Support

Erica Goodpaster — Fri, 21 Aug 2026 11:58:09 +0000

From Proscia on LinkedIn When evaluating an enterprise pathology platform, many life sciences organizations and diagnostic laboratories focus on the features it offers. This makes sense since scientists and pathologists will rely on that functionality every day. At Proscia, we believe that product functionality is one important part of the experience that we deliver to […]

The post Proscia: Getting to Know Kary Rogers: A Conversation with Proscia’s Head of Support first appeared on Tissuepathology.com.